
Sean R. Miller
Radiation Oncology
1500 E Medical Center Dr
Floor B2 C490
Ann Arbor, MI 48109
Floor B2 C490
Ann Arbor, MI 48109
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Quantitative lung tissue functional analysis for pulmonary adverse event risk assessment prior to thoracic radiotherapy.
Journal: Physics and imaging in radiation oncology
Published: February 17, 2026
Review of radiopharmaceutical therapy in prostate cancer.
Journal: Urologic oncology
Published: September 25, 2025
Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 10, 2025
Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 10, 2025
Reirradiation Special Medical Physics Consultations: Lessons Learned From Nearly 3000 Courses of Treatment.
Journal: International journal of radiation oncology, biology, physics
Published: September 16, 2024
Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care System.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 21, 2024
Local-Regional Therapy for Oligometastatic Colorectal Cancer.
Journal: Cancer journal (Sudbury, Mass.)
Published: July 23, 2024
Intricacies of human-AI interaction in dynamic decision-making for precision oncology.
Journal: Nature communications
Published: June 14, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System.
Journal: Cancer medicine
Published: May 29, 2024
Intricacies of Human-AI Interaction in Dynamic Decision-Making for Precision Oncology: A Case Study in Response-Adaptive Radiotherapy.
Journal: medRxiv : the preprint server for health sciences
Published: May 15, 2024
Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study.
Journal: The Lancet. Oncology
Published: May 06, 2024
Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer.
Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: June 17, 2023
Last Updated: 09/26/2026